glp-1 ocd medications get at the heart of addiction: study – WashU Medicine GLP-1 and Anesthesia: Considerations and

Once-weekly long-acting exenatide formulations have shown promise in significantly improving glycemic control and promoting weight loss in patients with inadequately controlled type 2 diabetes

amylophilus, P

The same repair idea is why it shows up in gut discussions, too

Bonomini M, Sirolli V, Settefrati N, Dottori S, Di Liberato L, Arduini A

Disulfiram acts by inducing nausea upon alcohol consumption, naltrexone is a mu-opioid receptor antagonist, therefore having broad action on the reward system, and the action of acamprosate is less well understood, but it is likely an allosteric modulator of GABAa receptors

(2022) 7:e160989